Ledger.Open graph →
SEC Form D · filed September 29, 2022

Avenzo Therapeutics, Inc

Offering
$171.5M
Sold
$31.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Brian Sun · San Diego, CAExecAthena Countouriotis · San Diego, CAExec · DirectorCarl Gordon · SAN FRANCISCO, CADirectorMohammad Hirmand · San Diego, CAExecCarl Gordon · Encinitas, CADirectorMichael Rome · New York, NYDirectorSimeon George · Cambridge, MADirectorBrian Sun · San Diego, CAExecAthena Countouriotis · San Diego, CAExec · DirectorCarl Gordon · CAMBRIDGE, MADirectorMichael Rome · New York, NYDirectorMohammad Hirmand · San Diego, CAExecSimeon George · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗